---
title: "\"Performance\" AIM VACCINE's losses widened to 675 million yuan last year"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/281110637.md"
description: "AIM VACCINE announced its full-year results for the year ended December last year, with a revenue of 1.166 billion yuan (RMB), a year-on-year decrease of 9.3%. The loss widened to 675 million yuan, compared to a loss of 277 million yuan in the same period last year; the loss per share was 0.55 yuan. No final dividend will be distributed"
datetime: "2026-03-31T02:08:40.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/281110637.md)
  - [en](https://longbridge.com/en/news/281110637.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/281110637.md)
---

# "Performance" AIM VACCINE's losses widened to 675 million yuan last year

AIM VACCINE (06660.HK) announced its full-year results for the year ended last December, with revenue of RMB 1.166 billion, a year-on-year decrease of 9.3%. Losses widened to RMB 675 million, compared to a loss of RMB 277 million in the same period last year; loss per share was RMB 0.55. No final dividend will be distributed

### Related Stocks

- [159849.CN](https://longbridge.com/en/quote/159849.CN.md)
- [159316.CN](https://longbridge.com/en/quote/159316.CN.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [520880.CN](https://longbridge.com/en/quote/520880.CN.md)
- [513700.CN](https://longbridge.com/en/quote/513700.CN.md)
- [159506.CN](https://longbridge.com/en/quote/159506.CN.md)
- [560600.CN](https://longbridge.com/en/quote/560600.CN.md)
- [512010.CN](https://longbridge.com/en/quote/512010.CN.md)
- [512290.CN](https://longbridge.com/en/quote/512290.CN.md)
- [159615.CN](https://longbridge.com/en/quote/159615.CN.md)
- [06660.HK](https://longbridge.com/en/quote/06660.HK.md)
- [513120.CN](https://longbridge.com/en/quote/513120.CN.md)
- [513060.CN](https://longbridge.com/en/quote/513060.CN.md)
- [516500.CN](https://longbridge.com/en/quote/516500.CN.md)
- [159837.CN](https://longbridge.com/en/quote/159837.CN.md)
- [159892.CN](https://longbridge.com/en/quote/159892.CN.md)
- [159992.CN](https://longbridge.com/en/quote/159992.CN.md)
- [588250.CN](https://longbridge.com/en/quote/588250.CN.md)
- [510660.CN](https://longbridge.com/en/quote/510660.CN.md)
- [159859.CN](https://longbridge.com/en/quote/159859.CN.md)
- [520690.CN](https://longbridge.com/en/quote/520690.CN.md)
- [516930.CN](https://longbridge.com/en/quote/516930.CN.md)
- [516820.CN](https://longbridge.com/en/quote/516820.CN.md)
- [588860.CN](https://longbridge.com/en/quote/588860.CN.md)
- [159102.CN](https://longbridge.com/en/quote/159102.CN.md)
- [159929.CN](https://longbridge.com/en/quote/159929.CN.md)
- [589720.CN](https://longbridge.com/en/quote/589720.CN.md)
- [588130.CN](https://longbridge.com/en/quote/588130.CN.md)

## Related News & Research

- [Analyst Reiterates Buy on Microbix, Citing Temporary China Slowdown and Growing Diversified Demand](https://longbridge.com/en/news/286665358.md)
- [Ab&B Bio-Tech Starts Early-Stage Trials for High-Yield RSV Vaccine as Trading Remains Suspended](https://longbridge.com/en/news/286268861.md)
- [HBM Holdings Says Director Probed by CSRC, Sees No Impact on Operations](https://longbridge.com/en/news/286197909.md)
- [20:03 ETHarbour BioMed Announces Promising Preclinical Data for LET003, Its First AI-Enabled Drug Candidate](https://longbridge.com/en/news/286688082.md)
- [Everest Medicines Director and Major Shareholder Raises Stake in Company](https://longbridge.com/en/news/286481551.md)